Drinking sugar-sweetened beverages may increase your risk of heart disease. These drinks are easy to overconsume, and they ...

In sharp contrast to earlier studies, patients with severe triple-vessel heart disease fared equally well whether they ...

Did you know men and women's heart cells prefer different kinds of fuel? Gender differences are emerging as scientists turn ...

Eli Lilly’s experimental drug, lepodisiran, reduces lipoprotein(a) (Lp[a]) levels by an average of 93.9 per cent in a ...

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with ...

High blood pressure increases the risk of developing metabolic syndrome, a group of health conditions that can lead to heart ...

Discover how the experimental drug lepodisiran dramatically lowers lipoprotein(a) levels, potentially transforming treatment ...

Eli Lilly And Co (NYSE:LLY), on Sunday, announced positive Phase 2 results for lepodisiran, an investigational small ...

Discover the key information about cardiovascular disease in Black men, including risk factors, prevention strategies, and ...

Eli Lilly (NYSE:LLY) experienced a 6% increase in price over the last quarter, coinciding with several major developments.

Several studies have reported that the coronavirus disease 2019 (COVID-19) can lead to heart rate variability (HRV), with the ...

“A major shift is needed from acute event-centred care to strategies focused on early diagnosis, prevention, and management ...